How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.
about
Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis.The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs.
P2860
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
How comparable are rates of ma ...... bility, in five RA registries.
@en
type
label
How comparable are rates of ma ...... bility, in five RA registries.
@en
prefLabel
How comparable are rates of ma ...... bility, in five RA registries.
@en
P2093
P2860
P50
P1476
How comparable are rates of ma ...... ability, in five RA registries
@en
P2093
Christopher Garwood
Dimitrios A Pappas
Eiichi Tanaka
Eisuke Inoue
Eveline Wesby-van Swaay
George Reed
Hisashi Yamanaka
Jeffrey D Greenberg
Johan Askling
Laura Horne
P2860
P304
P356
10.1136/ANNRHEUMDIS-2015-208105
P407
P577
2015-11-30T00:00:00Z